Thanks Enjay--it's exactly what I was looking for!
Post# of 151114
The last line of the quote--leronlimab "demonstrated a predictable, sustained response that has reduced the size of primary and metastatic tumors and reduced circulating tumor cells in all patients so far."
"All patients so far." I am speechless.
You know, I got into CYDY for Covid... but knowing that leronlimab seemed to have a place in HIV treatment and was promising in mTNBC provided a little insurance, so to speak. Made me feel better about the investment. And five years later we are an oncology company and part of a "cure" for HIV!
I missed that press release back in the day. In fact I didn't own any shares on March 2, 2020.
Also thanks to Misiu for her comments that got this thread rolling in the first place. Darn good memory!
--Sherlock--

